| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a7dfb0281008cb570feea037cd350c8f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dbdae384a9f1ad0588422c89ddc71a00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-06 |
| filingDate |
2015-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_210b993eeaeb5b3232ecf176e39e9ef2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_933ba00d6d0e1ddd16b28e004577e2bd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_98b623b3607d71309a8181902483782c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_32efa71679844b1b9ccaadf0af0df0fe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_204bff46c92e175f8bc9ae08e5efa21d |
| publicationDate |
2015-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
AU-2015268579-A1 |
| titleOfInvention |
Method for reducing the thromboembolic potential of a plasma-derived immunoglobulin composition |
| abstract |
The present invention provides methods for reducing the amidolytic and anti-complement activity (ACA) content of an immunoglobulin composition through the use of cation exchange chromatography. In a specific embodiment, the invention provides methods for reducing the Factor XI and/or Factor Xla and/or ACA content of an immunoglobulin composition by collecting the leading portion of a cation exchange eluate. The present invention also provides immunoglobulin composition having reduced levels of amidolytic activity, Factor XI, and/or Factor Xla, and/or ACA content. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3638693-A4 |
| priorityDate |
2011-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |